5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.62▲ | 1.63▼ | 1.63▼ | 1.69▼ | 1.83▼ |
MA10 | 1.65▼ | 1.66▼ | 1.66▼ | 1.81▼ | 1.69▼ |
MA20 | 1.67▼ | 1.70▼ | 1.73▼ | 1.92▼ | 1.48▲ |
MA50 | 1.76▼ | 1.76▼ | 1.93▼ | 1.71▼ | 1.52▲ |
MA100 | 1.79▼ | 2.14▼ | 2.07▼ | 1.48▲ | 1.62▼ |
MA200 | 2.20▼ | 2.04▼ | 1.83▼ | 1.50▲ | 2.01▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.003▼ | 0.000▼ | -0.070▼ | 0.047▲ |
RSI | 32.913▼ | 32.561▼ | 35.101▼ | 43.415▼ | 50.443▲ |
STOCH | 7.500▼ | 9.441▼ | 8.412▼ | 4.185▼ | 15.834▼ |
WILL %R | -80.000▼ | -82.609▼ | -90.476▼ | -100.000▼ | -88.571▼ |
CCI | -73.057 | -97.302 | -91.930 | -74.652 | -1.470 |
Saturday, September 06, 2025 12:15 PM
Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover speculation. There's speculation that a French pharmaceutical company is circling Ocular Therapeutix (NASDAQ:OCUL), according to traders, who ...
|
Saturday, September 06, 2025 12:15 PM
Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover speculation. There's speculation that a French pharmaceutical company is circling Ocular Therapeutix (NASDAQ:OCUL), according to traders, who ...
|
Thursday, September 04, 2025 02:01 PM
Senmiao Technology, BT Brands, and Urban-gro Inc. are the 3 Penny Stocks to watch on September 4, 2025, based on TipRanks’ Penny ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/09/25 | 1.69 | 1.69 | 1.57 | 1.57 | 280,755 |
17/09/25 | 1.70 | 1.7299 | 1.60 | 1.67 | 243,420 |
16/09/25 | 1.85 | 1.87 | 1.69 | 1.69 | 554,218 |
15/09/25 | 1.87 | 2.00 | 1.78 | 1.85 | 14,107,751 |
12/09/25 | 1.81 | 1.81 | 1.6629 | 1.69 | 89,226 |
11/09/25 | 1.78 | 1.8695 | 1.61 | 1.70 | 253,047 |
10/09/25 | 1.92 | 1.9298 | 1.72 | 1.72 | 167,265 |
09/09/25 | 1.90 | 2.00 | 1.85 | 1.90 | 165,544 |
08/09/25 | 2.22 | 2.4472 | 1.865 | 2.00 | 461,792 |
05/09/25 | 2.86 | 2.86 | 2.30 | 2.30 | 494,368 |
|
|
||||
|
|
||||
|
|